Biomerieux (France) Investor Sentiment

BIM Stock  EUR 91.55  0.40  0.44%   
About 62% of Biomerieux's investor base is looking to short. The analysis of current outlook of investing in Biomerieux SA suggests that many traders are alarmed regarding Biomerieux's prospects. Biomerieux's investor sentiment overview provides quick insight into current market opportunities from investing in Biomerieux SA. The current market sentiment, together with Biomerieux's historical and current headlines, can help investors time the market. In addition, many technical investors use Biomerieux SA stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
over a week ago at news.google.com         
bioMrieux Share Price Crosses Below 50 Day Moving Average of 105.77 - Defense World
Google News at Macroaxis
over two weeks ago at news.google.com         
bioMrieux Back on an important level - Marketscreener.com
Google News at Macroaxis
over two weeks ago at news.google.com         
France stocks mixed at close of trade CAC 40 up 0.29 percent - MSN
Google News at Macroaxis
over three weeks ago at news.google.com         
France stocks higher at close of trade CAC 40 up 0.20 percent By Investing.com - Investing.com
Google News at Macroaxis
over a month ago at news.google.com         
The total return for bioMrieux investors has risen faster than earnings growth over the last five ye...
Google News at Macroaxis
over a month ago at news.google.com         
bioMrieux S.A. Short Interest Update - Defense World
Google News at Macroaxis
over a month ago at news.google.com         
bioMrieux Shares Pass Below 50-Day Moving Average of 109.17 - Defense World
Google News at Macroaxis
over a month ago at news.google.com         
Top Moderna Shareholders - Investopedia
Google News at Macroaxis
over a month ago at news.google.com         
Investors Met With Slowing Returns on Capital At bioMrieux - Simply Wall St
Google News at Macroaxis
over two months ago at news.google.com         
France stocks mixed at close of trade CAC 40 down 0.86 percent - Investing.com
Google News at Macroaxis
over two months ago at news.google.com         
BioMrieux growth of over 6 percent in Q1 -April 09, 2024 at 0155 am EDT - Marketscreener.com
Google News at Macroaxis
over two months ago at news.google.com         
bioMrieux Shares Down 5.3 percent - Defense World
Google News at Macroaxis
over two months ago at news.google.com         
bioMrieuxs Conservative Accounting Might Explain Soft Earnings - Simply Wall St
Google News at Macroaxis
over two months ago at news.google.com         
bioMrieux S.A. Just Missed Earnings - But Analysts Have Updated Their Models - Simply Wall St
Google News at Macroaxis
over two months ago at news.google.com         
Full Year 2023 Biomerieux SA Earnings Call Transcript - GuruFocus.com
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Biomerieux that are available to investors today. That information is available publicly through Biomerieux media outlets and privately through word of mouth or via Biomerieux internal channels. However, regardless of the origin, that massive amount of Biomerieux data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Biomerieux news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Biomerieux relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Biomerieux's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Biomerieux alpha.

Biomerieux Performance against NYSE Composite

 Price Growth (%)  
       Timeline  

Complementary Tools for Biomerieux Stock analysis

When running Biomerieux's price analysis, check to measure Biomerieux's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomerieux is operating at the current time. Most of Biomerieux's value examination focuses on studying past and present price action to predict the probability of Biomerieux's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomerieux's price. Additionally, you may evaluate how the addition of Biomerieux to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments